Standard Chemical & Pharmaceutical Co., Ltd. (TWSE: 1720)
Health Care · Pharmaceuticals · TW
NT$56.90
+1.43% today · +14.8% 1Y
Standard Chemical & Pharmaceutical Co., Ltd. (TWSE: 1720) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $317.99M and employs 1,130 people.
Over the last twelve months the share price has gained 14.8%, trading between 48.64 and 60.55.
Tweenvest scores Standard Chemical & Pharmaceutical Co., Ltd. across four factors: quality 83/100, value 74/100, growth 57/100, dividend 50/100. Its strongest factor is quality.
1720 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $317.99M
- Revenue (TTM)
- $222.52M
- P/E
- 10.92
- EPS
- 5.21
- Dividend yield
- 3.20%
- Beta (5Y)
- -0.00
- 52-week high
- NT$60.55
- 52-week low
- NT$48.64
- Avg volume (3M)
- —
- Shares outstanding
- 178.70M
- Employees
- 1,130
- Next earnings
- —
About Standard Chemical & Pharmaceutical Co., Ltd.
Standard Chem & Pharm Co. Ltd. (SCP) is a Taiwanese enterprise specializing in the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical products, nutritional supplements, and Active Pharmaceutical Ingredients (APIs). The company's diverse offerings include medications targeting various therapeutic areas, such as the circulatory, digestive, and respiratory systems. Their portfolio also features antihistamines, central nervous system (CNS) agents, metabolism-regulating drugs, anti-microbial treatments, and topical preparations for skin and mucous membrane conditions. Beyond finished drug products, SCP provides APIs for both human and veterinary applications, as well as various pharmaceutical excipients. Founded in 1967, Standard Chem & Pharm Co. Ltd. maintains its corporate headquarters in Tainan City, Taiwan.
- ISIN
- TW0001720001
- Founded
- 1967
- Listed since
- Jan 4, 2000
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ouro Fino Saúde Animal Participações S.A.BOVESPA: OFSA3 | $323.80M | R$30.00 | +7.57% |
| Solara Active Pharma Sciences LimitedNSEI: SOLARA | $321.23M | Rs644.35 | -9.86% |
| Gulf Pharmaceutical Industries P.S.C.ADX: JULPHAR | $320.80M | AED1.02 | -0.97% |
| HLB Pharmaceutical Co., Ltd.KOSDAQ: A047920 | $320.33M | ₩13,130.00 | +31.17% |
| Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,LtdSZSE: 301130 | $316.94M | CN¥28.12 | -1.37% |
| Shukra Pharmaceuticals LimitedBSE: 524632 | $304.29M | Rs66.99 | +8.33% |
| Guiyang Xintian Pharmaceutical Co.,Ltd.SZSE: 002873 | $303.47M | CN¥8.55 | +2.03% |
| SNDL Inc.NasdaqCM: SNDL | $303.37M | $1.22 | -1.61% |
Figures last refreshed Oct 11, 2026.